AA
GILD icon

Apriem Advisors’s Gilead Sciences GILD Stock Holding History

Apriem Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,275
Closed -$213K – 135
2019
Q1 		$213K Sell
3,275
-162
-5% -$10.8K 0.06% 119
2018
Q4 		$215K Sell
3,437
-800
-19% -$55.9K 0.08% 113
2018
Q3 		$327K Buy
4,237
+150
+4% +$11.3K 0.07% 101
2018
Q2 		$290K Sell
4,087
-200
-5% -$14.1K 0.07% 103
2018
Q1 		$323K Buy
4,287
+800
+23% +$63.6K 0.08% 92
2017
Q4 		$250K Sell
3,487
-738
-17% -$56K 0.06% 111
2017
Q3 		$342K Buy
4,225
+446
+12% +$34.1K 0.09% 95
2017
Q2 		$267K Sell
3,779
-591
-14% -$39.3K 0.07% 107
2017
Q1 		$297K Sell
4,370
-700
-14% -$49.2K 0.08% 98
2016
Q4 		$363K Sell
5,070
-23,385
-82% -$1.74M 0.11% 88
2016
Q3 		$2.25M Buy
28,455
+499
+2% +$40.5K 0.67% 39
2016
Q2 		$2.33M Buy
27,956
+1,368
+5% +$121K 0.76% 34
2016
Q1 		$2.44M Sell
26,588
-772
-3% -$69.6K 0.96% 29
2015
Q4 		$2.77M Sell
27,360
-491
-2% -$51.1K 0.99% 33
2015
Q3 		$2.73M Buy
27,851
+1,171
+4% +$130K 1.01% 30
2015
Q2 		$3.12M Sell
26,680
-3,258
-11% -$356K 1.07% 31
2015
Q1 		$2.94M Buy
29,938
+3,553
+13% +$361K 1.02% 34
2014
Q4 		$2.49M Buy
26,385
+9,205
+54% +$952K 0.92% 39
2014
Q3 		$1.83M Sell
17,180
-550
-3% -$53.9K 0.7% 50
2014
Q2 		$1.47M Buy
17,730
+2,100
+13% +$163K 0.56% 53
2014
Q1 		$1.11M Buy
15,630
+15,330
+5,110% +$1.2M 0.42% 59
2013
Q4 		$23K Buy
+300
New +$20.9K 0.01% 277

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Apriem Advisors's GILD Position: Q2 2019 in Review

Apriem Advisors sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 3,275 shares — an estimated $213K sold.

Apriem Advisors first reported a position in GILD in Q4 2013 and held it in 22 quarters. The position peaked at $3.12M in Q2 2015. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Apriem Advisors reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • Apriem Advisors sold 3,275 Gilead Sciences shares in Q2 2019, an estimated $213K.
  • Apriem Advisors first reported a position in Gilead Sciences in Q4 2013 and held it in 22 quarters.
  • Apriem Advisors's Gilead Sciences position peaked at $3.12M in Q2 2015.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Apriem Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.